Cargando…
Modified Factor VIII and Factor IX recombinant products
Autores principales: | Santagostino, Elena, Mancuso, Maria Elisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925599/ http://dx.doi.org/10.1097/HS9.0000000000000127 |
Ejemplares similares
-
Prognostic factors and treatment of secondary leukemia
por: Voso, Maria Teresa, et al.
Publicado: (2018) -
Mechanisms underlying transcription factor deregulation in acute lymphoblastic leukemia
por: Cools, Jan
Publicado: (2018) -
Transfusion in patients with massive blood loss: evidence when, for whom and what products are best
por: Zwaginga, Jaap Jan
Publicado: (2018) -
Advances in hemoglobin disorders
por: Cappellini, Maria Domenica
Publicado: (2018) -
New concepts in acute lymphoblastic leukemia frontline trials
por: Oskarsson, Trausti, et al.
Publicado: (2018)